Cetera Investment Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8M | Sell |
60,196
-4,578
| -7% | -$2.04M | 0.05% | 416 |
|
|
2025
Q1 | $31.4M | Buy |
64,774
+10,817
| +20% | +$5.24M | 0.06% | 328 |
|
|
2024
Q4 | $21.7M | Buy |
53,957
+328
| +0.6% | +$132K | 0.05% | 400 |
|
|
2024
Q3 | $24.9M | Buy |
53,629
+1,616
| +3% | +$752K | 0.05% | 358 |
|
|
2024
Q2 | $24.4M | Buy |
52,013
+1,146
| +2% | +$537K | 0.06% | 344 |
|
|
2024
Q1 | $21.3M | Buy |
50,867
+33,530
| +193% | +$14M | 0.05% | 369 |
|
|
2023
Q4 | $7.05M | Buy |
17,337
+1,531
| +10% | +$623K | 0.06% | 329 |
|
|
2023
Q3 | $5.5M | Buy |
15,806
+425
| +3% | +$148K | 0.05% | 384 |
|
|
2023
Q2 | $5.41M | Buy |
15,381
+1,464
| +11% | +$515K | 0.05% | 383 |
|
|
2023
Q1 | $4.38M | Sell |
13,917
-1,060
| -7% | -$334K | 0.04% | 431 |
|
|
2022
Q4 | $4.33M | Buy |
14,977
+5,200
| +53% | +$1.5M | 0.04% | 429 |
|
|
2022
Q3 | $2.83M | Sell |
9,777
-941
| -9% | -$272K | 0.06% | 352 |
|
|
2022
Q2 | $3.02M | Sell |
10,718
-3,396
| -24% | -$957K | 0.05% | 389 |
|
|
2022
Q1 | $3.68M | Buy |
14,114
+544
| +4% | +$142K | 0.05% | 359 |
|
|
2021
Q4 | $2.98M | Sell |
13,570
-312
| -2% | -$68.5K | 0.04% | 427 |
|
|
2021
Q3 | $2.52M | Sell |
13,882
-819
| -6% | -$149K | 0.04% | 441 |
|
|
2021
Q2 | $2.96M | Buy |
14,701
+868
| +6% | +$175K | 0.05% | 403 |
|
|
2021
Q1 | $2.97M | Sell |
13,833
-3,368
| -20% | -$724K | 0.06% | 328 |
|
|
2020
Q4 | $4.07M | Buy |
17,201
+12,157
| +241% | +$2.87M | 0.08% | 268 |
|
|
2020
Q3 | $1.37M | Buy |
5,044
+3,738
| +286% | +$1.02M | 0.11% | 206 |
|
|
2020
Q2 | $379K | Buy |
+1,306
| New | +$379K | 0.04% | 414 |
|
|
2018
Q4 | – | Sell |
-1,128
| Closed | -$217K | – | 506 |
|
|
2018
Q3 | $217K | Buy |
+1,128
| New | +$217K | 0.03% | 445 |
|